Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00135291 · ClinicalTrials.gov registry record · Phase 2
Effect of Leukoreduced Blood Transfusions on Infection Following Trauma
A Phase 2 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 2
- Development phase
- 300
- Enrollment target
NCT00135291 is a Phase 2 study that has completed, run by University of Washington. The registered enrollment target is 300 participants.
The verdict
NCT00135291, a Phase 2 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 300 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if leukoreduced blood transfusions reduce the risk of infection following trauma. Specifically, the investigators intend to evaluate whether there are clinically relevant differences in the rates of infection and in the severity of multiple organ failure in critically injured trauma patients receiving leukoreduced blood products compared to those receiving standard allogeneic blood products.
Interventions
- PROCEDURE Leukoreduced blood transfusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2003-02 |
| Est. Completion | 2004-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00135291
The ClinicalTrials.gov registry entry for NCT00135291 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Leukoreduced blood transfusion is the first listed.
NCT00135291 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00135291 about?
NCT00135291 is a clinical study titled "Effect of Leukoreduced Blood Transfusions on Infection Following Trauma". The purpose of this study is to determine if leukoreduced blood transfusions reduce the risk of infection following trauma. Specifically, the investigators intend to evaluate whether there are clinically relevant differences in the rates of infection and in the severity of multiple organ failure in ...
What is the current status of trial NCT00135291?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 300 participants. The study started on 2003-02. Estimated completion is 2004-09.
What interventions are being tested in trial NCT00135291?
The interventions under investigation include: Leukoreduced blood transfusion (PROCEDURE).
Who is sponsoring clinical trial NCT00135291?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.